Table 2 Descriptive statistics for studies included in the ideation analysis.
Site | Age HC (years) | Age CC (years) | Age ideation | % female HC | % female CC | % female ideation | Total N HC | Total N CC | Total N Ideation |
|---|---|---|---|---|---|---|---|---|---|
A. Mood disorders only sample | |||||||||
Boystown (USA) | 17.0 (14–18) | 17.0 (13–19) | 17.0 (14–18) | 22.2 | 60.0 | 54.4 | 9 | 10 | 11 |
DEP-ARREST-CLIN – MOODS (France) | 21.0 (20–25) | - | 22.0 (18–25) | 54.5 | - | 70.0 | 11 | 0 | 10 |
EPISCA (Netherlands) | 14.0 (13–19) | 15.5 (13–16) | 16.0 (13–20) | 86.2 | 83.3 | 88.9 | 29 | 6 | 18 |
FOR2107-Marburg | 23.0 (18–25) | 24.0 (18–25) | 23.0 (18–25) | 67.2 | 84.4 | 49.1 | 125 | 32 | 57 |
FOR2107-Münster (Germany) | 23.0 (18–25) | 22.0 (18–25) | 23.0 (19–25) | 71.7 | 77.3 | 50.0 | 106 | 22 | 26 |
Houston BD (USA) | 14.0 (8–25) | 14.0 (8–25) | 14.0 (10–24) | 54.3 | 31.6 | 66.7 | 81 | 57 | 9 |
MDD Cohort (China) | 23.0 (22–24) | 22.0 (18–25) | 21.0 (16–25) | 80.0 | 44.4 | 66.7 | 5 | 9 | 12 |
Muenster Neuroimaging Cohort (Germany) | 22.0 (17–25) | 23.0 (16–25) | 22.0 (17–25) | 47.5 | 57.9 | 50.0 | 80 | 19 | 40 |
Sydney Brain and Mind Centre (Australia) | 23.0 (18–25) | 19.5 (12–25) | 17.0 (15–22) | 60.0 | 61.4 | 77.8 | 25 | 44 | 9 |
University of Minnesota (USA) | 16.0 (12–19) | 16.0 (13–20) | 16.0 (12–19) | 54.5 | 74.3 | 84.0 | 22 | 35 | 25 |
University of Texas- Austin -Bipolar Seed Program (USA) | 21.0 (18–25) | 21.0 (18–25) | 20.5 (19–25) | 69.2 | 75.0 | 83.3 | 26 | 12 | 6 |
Total | 22.0 (8–25) | 19.0 (8–25) | 20.0 (10–25) | 62.4 | 61.0 | 61.4 | 519 | 246 | 223 |
B. Transdiagnostic sample | |||||||||
Boystown (USA) | 17.0 (14–18) | 16.0 (12–19) | 16.0 (12–18) | 22.2 | 30.7 | 63.0 | 9 | 114 | 27 |
DEP-ARREST-CLIN – MOODS (France) | 21.0 (20–25) | 22.0 (18–25) | 54.5 | 70.0 | 11 | 0 | 10 | ||
EPISCA (Netherlands) | 14.0 (13–19) | 16.0 (13–20) | 16.0 (12–20) | 86.2 | 83.3 | 87.5 | 29 | 12 | 24 |
FOR2107-Marburg (Germany) | 23.0 (18–25) | 24.0 (18–25) | 23.0 (18–25) | 67.2 | 84.4 | 49.1 | 125 | 32 | 57 |
FOR2107-Münster (Germany) | 23.0 (18–25) | 22.0 (18–25) | 23.0 (19–25) | 71.7 | 77.3 | 50.0 | 106 | 22 | 26 |
Houston BD (USA) | 14.0 (8–25) | 14.0 (8–25) | 14.0 (10–24) | 54.3 | 31.6 | 66.7 | 81 | 57 | 9 |
MDD Cohort (China) | 23.0 (22–24) | 22.0 (18–25) | 21.0 (16–25) | 80.0 | 44.4 | 66.7 | 5 | 9 | 12 |
Muenster Neuroimaging Cohort (Germany) | 22.0 (17–25) | 23.0 (16–25) | 22.0 (17–25) | 47.5 | 57.9 | 50.0 | 80 | 19 | 40 |
SOCAT (Turkey) | 23.0 (17–25) | 23.0 (19–25) | 100.0 | 95.0 | 37 | 0 | 20 | ||
Sydney Brain and Mind Centre (Australia) | 23.0 (18–25) | 19.0 (12–25) | 20.0 (14–25) | 60.0 | 61.4 | 85.7 | 25 | 83 | 21 |
University of Minnesota (USA) | 16.0 (12–19) | 16.0 (13–20) | 16.0 (12–19) | 54.5 | 74.3 | 84.0 | 22 | 35 | 25 |
University of Texas- Austin -Bipolar Seed Program (USA) | 21.0 (18–25) | 21.0 (18–25) | 20.5 (19–25) | 69.2 | 75.0 | 83.3 | 26 | 12 | 6 |
UWashington/Harvard (USA) | 11.0 (8–16) | 10.5 (8–16) | 14.5 (8–16) | 50.0 | 50.0 | 58.3 | 50 | 24 | 12 |
Total | 21.0 (8–25) | 17.0 (8–25) | 20.0 (8–25) | 63.7 | 52.5 | 65.7 | 606 | 419 | 289 |
